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covalently
coupled
to plasma proteins
should be a useful radioactive
tracer
for detecting
the tissue and cellular sites of catabolism
of long lived circulating
proteins.

There is extensive information
concerning
the sites of synthesis and kinetics of turnover
of plasma proteins; however,
there is little firm evidence concerning
their mechanisms
of
clearance from the circulation
or their tissue sites of degradation (2-4). Perhaps the greatest technical difficulty
in obtaining this information
has been the absence of a suitable
radioactive
label with which to monitor the sites of catabolism
of proteins with the long circulating
half-lives characteristic
of plasma proteins. In general, the rate of intracellular
degradation of plasma proteins within lysosomes far exceeds the
rate of clearance of these long lived proteins. Thus, if plasma
proteins are labeled with conventional
labels, such as ? or
radioactive
amino acids, the tracer does not accumulate at the
site of catabolism,
but, rather, as the protein is degraded to
monomeric
products which exit from the lysosome, the label
is lost to cellular or extracellular
metabolic pools, or both. In
contrast, the sites of catabolism
of proteins with short circulating half-lives
are readily
identified
since their rates of
clearance are relatively
rapid, compared
to the rate of lysosomal digestion. It has been possible, therefore, to identify the
liver as the primary site for catabolism
of [“H,%u]asialoceruloplasmin
(5) and lz51-RNase B (6) injected
in rats, and
bovine /3-glucuronidase
injected in mice (7), all proteins which
exhibit half-lives of 15 min or less.
In order to circumvent the difficulties
inherent in determining the in. uiuo fate of long lived plasma proteins, a tracer is
needed which will 1) not affect mechanisms
of protein clearance and catabolism,
2) be resistant to degradation
by lysosomal hydrolases, and 3) accumulate
in lysosomes at the site
of the labeled protein’s
degradation.
We hypothesized
that
sucrose (Glcpcyl-ZPFru,)
covalently
attached
to protein
through its glucosyl moiety might fulfill these criteria for the
following reasons. First, because of the stable equilibration
of
inulin
(a fructan)
and rafiinose
(RAF, Galpcul-GGlcpal2/3Frun into plasma and extravascular
spaces in uivo (8), it
seemed unlikely
that the terminal
fructose residues on a
protein would serve as recognition
markers for a carbohydrate-dependent
clearance process analogous to those already
described for galactose (9), fucose (lo), mannose (11, 12), and
N-acetylglucosamine
(13,14) terminal glycoproteins.
Second,
because of the absence of significant
levels of mammalian
lysosomal sucrase activity (15), it seemed unlikely
that hydrolysis of the sucrose moiety would occur either before or
after degradation
of the protein. Finally, since sucrose does
not readily diffuse from lysosomes (15), it or its amino acid
conjugate should accumulate at this subcellular
site of protein
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The primary
tissue
sites of catabolism
of plasma
proteins
with long circulating
half-lives
are unknown.
It has been difficult
to identify
these sites because
plasma
proteins
are delivered
to tissues at relatively
slow rates
but are rapidly
degraded
intracellularly
within
lysosomes.
Therefore,
a tracer
attached
to protein is lost from the site of uptake
before
an amount
sufficient
for quantitation
can accumulate.
We hypothesized that sucrose (Glupal-2
/3Fruf) would be a useful
label to circumvent
this difficulty
because of the stability of sucrose
in lysosomes;
and thus, sucrose should
remain
in tissue long after the protein
to which it was
attached
had been degraded
to products
released
from
the lysosome.
[G-3HJRaffinose
(RAF, GalpalGlupcwl2flFruf)
was selected
as the vehicle
for attaching
sucrose to protein.
[31XjRAF
was converted
to the C-6
aldehydogalactose
form with
galactose
oxidase
and
then covalently
coupled
to protein
by reductive
amination
using NaBH3CN.
[‘H]RAF
was coupled
first to two relatively
long lived
plasma proteins,
bovine serum albumin
and fetuin. The
half-lives
of these proteins
in the rat circulation
(&,* =
-24 h) was unchanged,
suggesting
that RAF did not
alter
the normal
mechanisms
of protein
clearance.
When attached
to short lived proteins
with known
sites
of catabolism,
such as asialofetuin,
RNase B, and heatdenatured
albumin,
neither
the tissue nor cellular
sites
of uptake
of the proteins
were altered.
Thus, 13H]RAFasialofetuin
was recovered
almost
exclusively
(>90%)
in the liver
parenchymal
cell fraction,
while
both
[JHJRAF-labeled
RNase B and heat-denatured
albumin
were recovered
primarily
(>85%) in nonparenchymal
cells. In addition,
the RAF label was observed
to reside
stably (tl,2 > 100 h) in the liver following
degradation
of
the carrier
protein;
in contrast,
radioactivity
from “‘Ilabeled
asialofetuin
or RNase B was rapidly
(tl,z < 30
min) lost from liver. Radioactivity
from 13H]RAF-proteins was recovered
in a lysosomally
enriched
subcellular fraction
in liver and consisted
of a low molecular
weight
species
(-llOO),
containing
both glucose
and
fructose
in a ratio similar
to that in the original
protein. The results of these studies establish
that 13H]RAF
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catabolism,
despite the fact that other components
of the
protein would exit from the lysosome following degradation.
As a vehicle for the attachment
of sucrose to protein, we
chose the trisaccharide
[G-3H]raffinose
as our radioactive
starting material. Oxidation of the C-6 hydroxyl of the galactose residue, using galactose oxidase (16), provided an aldehyde function
which could be readily coupled to protein,
under mild conditions,
using NaBH3CN
(17). We present
below the results obtained in vitro for the coupling of RAF’
to several proteins by this method. We also present our results
from studies on the comparative
fates of 12?- and [“HIRAFlabeled proteins in viuo, as a test of our hypothesis that RAF
attached to protein would be a stable, inert, label useful for
determining
the organ and cellular sites of plasma protein
catabolism.
EXPERIMENTAL

PROCEDURES

Proteins

lation fluid (Beckman
Bio-Solv
EP). Weighed
portions
(-1 g) of tissue
from
““I-protein
injection
experiments
were counted
directly
in a
Beckman
Gamma
4000 gamma counter.
Isolation
of parenchymal
and
non-parenchymal
cells of liver by collagenase
digestion
and differential centrifugation
was carried
out as previously
described
(6). Subcellular
fractionation
of liver by differential
centrifugation
into nuclear, mitochondrial/lysosomal,
and supernatant
fractions
was performed
according
to Gregoriadis
and Sourkes
(22) using P-N-acetylhexosaminidase
activity
(23) as a lysosomal
marker
enzyme.
In order to characterize
products
resulting
from the in uiuo degradation of [gH]RAF-labeled
proteins,
livers were taken at various
times
postinjection
of heat-denatured
albumin
or asialofetuin;
the livers
were homogenized
in 4 volumes
of H20, frozen, and thawed
four to
five times
and then centrifuged
at 12,000 x g for 30 min. The
supernatant,
containing
90 to 100% of the original
radioactivity,
was
then passed
through
an Amicon
PM-10
filter
(nominal
molecular
weight cut off, lO,OOO), and 95 to 100% of the supernatant
radioactivity
was recovered.
The ultrafiitrate
was then lyophilized,
redissolved
in
a small volume
of 0.1 M ammonium
acetate,
and chromatographed
on
a Bio-Gel
P2 column.
Radioactive
peaks were pooled and lyophilized,
and their content
of radioactive
sugars was determined
following
hydrolysis
in 2.0 N trifluoroacetic
acid at 110°C for 3 h. Component
sugars were separated
by paper chromatography
in a butanol/pyridine/water
(9:5:4)
solvent
system
and visualized
using a sodium
periodate/silver
nitrate
staining
procedure
(24). Radioactivity
was
located
and quantitated
by counting
5-mm sections
of the paper
chromatogram
directly
in scintillation
fluid containing
10% H20.
RESULTS

In Vitro

Experiments:

Protein

Modification

The overall scheme for the production
of raffinaldehyde
and its coupling to protein is shown in Fig. 1. As indicated,
attachment of carbohydrate
to protein by reductive amination
required the presence of an aldehyde function on the sugar.
This aldehyde function was introduced
at the C-6 position of
the galactose moiety of RAF using galactose oxidase. Catalase
was included in the incubation
mixture in order to destroy
H202 produced during the oxidation reaction (16). Because of
the selectivity
of NaBH3CN
for reduction
of Schiff bases
above pH 5 (25), the coupling reaction theoretically
could be
carried out simultaneously
with the generation
of aldehyde.
However,
since preliminary
experiments
indicated
that
NaBH3CN was inhibitory
to galactose oxidase, the two reactions were carried out sequentially.
A pH of 7.5 was chosen as
the pH for coupling in order to keep plasma proteins close to
physiologic
pH and yet have conditions
alkaline enough to

raphy on Bio-Gel P-150 (albumin, fetuin) or Sephadex G-75 (Pharmacia, RNase B) columns in 0.1 N ammonium acetate.
Column
effluents
or both,
redissolved

were monitored
for absorbance
at 280 nm or radioactivity,
and appropriate
fractions
were pooled,
lyophilized,
and
in 0.9% NaCl for injection
experiments.
In Viva Experiments-Experiments
were
conducted
in male
Sprague-Dawley
rats (175 to 225 g) under ether anesthesia.
Experiments with RNase B were carried
out in nephrectomized
animals
as
previously
described
(6). For half-life
determinations,
proteins
were
injected
intracardially
and blood samples
were removed
at timed
intervals
from lateral
tail veins. After
centrifugation,
radioactivity
was determined
in measured
plasma aliquots.
Organs were thoroughly
perfused
with saline (0.9% NaCl solution)
before sampling
for radioactivity
determinations
(6). For measurement
of ‘H radioactivity,
weighed
aliquots
of tissue were homogenized
in 4 volumes
of H&,
and O.l- to 0.2-ml aliquota
were solubilized
overnight
at 25°C in 0.25
ml of 20% sodium
dodecyl
sulfate;
when decolorization
was needed,
10 to 20 ~1 of 30% Hz02 were added and samples
were heated at 50°C.
3H radioactivity
was counted
in a Triton
X-100 toluene-based
scintil..--____’ The abbreviation
used is: RAF, raffinose.

Na BH,CN

FIG. 1. General
reaction
sequence
for the enzymatic
raffinaldehyde
and ita chemical
attachment
to protein.

production

of
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Materials-The
following
materials
were purchased
from the indicated
sources:
[G-JH]RAF
(-1500
mci/mmol)
and Na’?
(New
England
Nuclear);
‘*?-human
serum
albumin,
(Mallinckrodt
Laboratories);
RAF,
Glu, Gal, and Fru (P & L Laboratories);
galactose
oxidase,
catalase,
insolubihzed
neuraminidase,
and
NaBH&N
(Sigma).
Bovine
serum albumin
(Pentex
Laboratories)
was heat-denatured
according
to the method
of Cohen and Gordon
(IS). RNase
B (Sigma type XII-B)
was assayed,
purified,
and iodinated
as previously described
(6, 11). Asialofetuin
was prepared
from fetuin (Grand
Island Biologic
Co.) using insolubilized
neuraminidase
at 25°C for 18
h in 0.1 N sodium
acetate,
pH 5.2; sialic acid release
was 75% of
theoretical
as judged by the thiobarbituric
acid assay (19). ‘““I-labeled
albumin,
fetuin,
and asialofetuin
were prepared
using the lactoperoxidase technique
(20) and reisolated
by chromatography
on Bio-Gel
P-150 (Bio-Rad
Co.).
Coupling of RAF to Protein-A
typical
reaction
mixture
for the
conversion
of RAF to raffinaldehyde
contained
1 pmol of RAF, 20
units of galactose
oxidase
(150 pg of protein),
and 130 units of catalase
(10 pg of protein)
in 1 ml of 0.1 N potassium
phosphate
buffer, pH 7.5,
and was incubated
for 4 h at 37°C.
Using
the Nelson-Somogyi
procedure
(21) to monitor
aldehyde
production,
75 to 80% of the
theoretical
amount
of aldehyde
was generated
under these conditions
(16). Longer
times of incubation,
further
additions
of enzyme,
or
increasing
the initial
amount
of enzyme
did not alter the yield of
aldehyde.
Aldehyde
generated
in this manner
was stable to freezing
for at least 10 days. In the coupling
procedure,
protein
in 0.1 N
potassium
phosphate,
pH 7.5, was mixed with 1 to 3 molar equivalents
of aldehyde,
and then NaBH&N
was added in the same buffer to a
final concentration
of 1 mg/ml
(17 mM); coupling
was carried
out for
18 to 24 h at room temperature
in a sealed tube. The kinetics
or
extent
of coupling
were determined
in aliquots
removed
at desired
times by measuring
radioactivity
or anthrone-positive
(21) material,
precipitable
by acid, or both. Albumin
was precipitated
by the addition of an equal volume
of 10% trichloroacetic
acid; fetuin and RNase
B were precipitated
with 5% phosphotungstic
acid in 2 N HCl, and
2.5% uranyl
acetate in 12.5% trichloroacetic
acid, respectively.
Radiolabeled protein
was isolated
from incubation
mixtures
by chromatog-
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TIME

(HOURS)

2. Kinetics
of coupling
of raffinaldehyde
to albumin.
Equimolar (0.1 mru) amount
of raffbmldehyde
and albumin
were incubated
at pH 7.5 in the presence
of 1 mg/ml
of NaBH&N;
at indicated
times
aliquots
were removed
and anthrone-positive
or radioactive
material
precipitable
by acid, or both, were quantitated
as described
under
“Experimental
Procedures.”
FIG.

Proteins
TABLE

Effect

of varying

reaction

conditions
protein
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I
on the coupling

of raffinose

to

Conditions”
EXperimerit

Raftin-

Tem-

pen-

[NaBH&N]

ture

Resuld

;.$;
protein’

[Protein]
mol raffi-

“C

nose/h

rnM

mol protein

1”
2
3
4

25
25
25
25

17
34
8.5
1.7

1:l
1:l
1:l
1:l

0.1
0.1
0.1
0.1

5
6

37
4

17
17

1:l
1:l

0.1 mM albumin
0.1 mru albumin

7
8

25
25

17
17

lo:1
3O:l

9

10

25
25

17
17

11

25

17

I:1
1:l
1:l

miu albumin
mM albumin
mru albumin
mM albumin

0.01 mM albumin
0.01 mM albumin

0.2 mM

f&Uin

0.2 mM asialofetuin
0.2 mrvr RNase B

33
33
20.5
10.9
36
17
100
210

20
1
10

“All
coupling
reactions
carried
out in 1 ml of 0.1 N potassium
phosphate
buffer,
pH 7.5, for 24 h with other parameters
varied as
indicated,
17 mM NaBH:,CN
= 1 mg/ml.
’ Amount
of raffinose
coupled
based on acid-precipitable
radioactivity.
’ Raftinaldehyde
generated
from 1 mM raffinose
at pH 7.5, 37°C.
using galactose
oxidase
and measured
by the Nelson
procedure
as
described
under “Experimental
Procedures.”
’ Conditions
of this reaction
defined as standard.

proteins tested (Experiments
9 to 11). As seen in Table I,
asialofetuin
was a much poorer substrate for the coupling
reaction than fetuin, itself; therefore, [3H]RAF-asialofetuin
was prepared by enzymatic desialylation
of [“HIRAF-fetuin.
The differential
reactivity
of fetuin and asialofetuin
in the
coupling reaction may result from a conformational
change in
fetuin’s structure upon removal of charged sialic acid residues.
Alterations
in other reaction parameters, particularly
pH and
time of incubation
(26), can be expected to enhance the extent
of RAF attached to proteins; in order to minimize structural
alterations in proteins to be studied in uiuo particularly
gentle
conditions for coupling were chosen in these experiments.
In Viuo Experiments
Half-life Studies-Alterations
in protein structure are often
reflected by changes in their circulating
half-life in uiuo (2).
Therefore, by comparing the half-lives of l*‘I- and [3H]RAFlabeled proteins in uiuo, the effect of RAF attachment on this
biological property of proteins can be evaluated. The results
of studies comparing the kinetics of clearance of several lz51and [3H]RAF-labeled
proteins are shown in Fig. 3. Panel A
demonstrates
that, whether labeled with “‘1 or [“HIRAF, both
asialofetuin
and RNase B were rapidly cleared from the
circulation.
The rapid kinetics of clearance were expected
since these proteins are recognized by separate carbohydratedependent
clearance systems specific for glycoproteins
with
terminal galactose (asialofetuin
(9)) and mannose (RNase B
(11)) residues. The data of Panel A indicated that the attachment of RAF did not prolong the circulating
half-life
of
asialofetuin
and RNase B by interfering
with these specific
recognition
systems.
In Fig. 3B, the circulating
half-lives of ‘*‘I- and [“H]RAF
derivatives
of fetuin, a long lived protein, are compared. In
this experiment
fetuin was iodinated
under mild conditions
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allow coupling to proceed at a reasonable rate (17, 26). The
gel chromatographic
profiles of modified proteins were identical to those of the starting preparations;
RNase B enzymatic
activity was unaffected
by attachment
of approximately
0.1
mol of RAF/mol
of protein.
The kinetics of attachment
of RAF to albumin under the
conditions
chosen as standard are illustrated
in Fig. 2. The
reaction was found to proceed at a relatively
rapid rate for
approximately
4 h and then continued more slowly thereafter.
It should be noted that the amount of protein-bound
carbohydrate (acid-precipitable)
was consistently found to be somewhat greater when determined
by the anthrone method (21)
than by radioactivity
measurements.
The reported specific
activity of the commercial
[“H]RAF
was determined
and
found to be correct, and its purity was confirmed
by paper
chromatography.
There was also no evidence of hydrolysis of
[3H]RAF to its component sugars during the incubation
with
galactose oxidase or during the coupling reaction. The discrepancy between anthrone and radioactivity
measurements
may be explained by a kinetic isotope effect resulting from
tritiation
at the C-6 position of galactose and preferential
oxidation of the unlabeled RAF by galactose oxidase. Neither
increasing
the time cf exposure of [“HIRAF
to galactose
oxidase, nor increasing the amount of enzyme in the standard
incubations
affected the extent of coupling of radioactivity
to
protein. Since radioactivity
was the only parameter
which
could be conveniently
assessed in either in uiuo experiments
or when RAF was coupled to glycoproteins,
the amount of
RAF coupled was normally
based on the specific activity of
the [3H]RAF used. Under the standard conditions described
in Fig. 2, 30 to 38 nmol of RAF were routinely
coupled/100
nmol of albumin.
Table I describes the effect of varying selected reaction
parameters
on the amount of RAF bound to protein. The
amount of RAF attached to albumin did not increase when
the NaBH3CN concentration
was greater than 1 mg/ml (Experiment 2) but was decreased at lower concentrations
(Experiments
3 and 4). In control experiments
RAF was not
coupled to protein unless NaBH3CN was included in incubation mixtures. The extent of coupling was not affected when
the reaction was incubated
at 37°C (Experiment
5) but was
decreased approximately
65% at 4°C (Experiment
6). The
proportion
of RAF coupled to albumin did not increase in a
linear fashion when the proportion
of aldehyde in the reaction
mixture was increased (Experiments
7 and 8), suggesting a
limited number of kinetically
accessible amino groups under
the conditions
used. Finally,
under standard
conditions
a
characteristic
amount of RAF was bound to each of the
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n [3H]

h

&
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P
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ALBUMIN

.

RAFFINOSEALBUMIN

‘251,

1

ASIALOFETUIN

20
0
\

50
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(MINUTES)

100

8

- t g22.4

40
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72

104

8

40
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(HOURS)

3. Kinetics
of clearance
of various
“‘1. and [“HIRAF-labeled
proteins
from the rat circulation.
Animals
were injected
with radiolabeled compound
and blood samples
were taken at indicated
times;
radioactivity
was determined
in measured
plasma
aliquots.
Data is
based on at least two animals/experiment
and points
represent
average values, which
typically
varied
by 5 percentage
points. Panel A,
A-A,
2 x 10”; cpm (0.1 mg) of ‘*“I-asialofetuin;
A-A,
2.8 X 10”
FIG.

using the lactoperoxidase
technique
(20) and then reisolated
by gel chromatography
so that minimal
denaturation
was
expected. The chromatographic
profile and half-life of [3H]RAF-fetuin
were essentially
identical
to that of ‘““I-fetuin,
suggesting that the coupling of RAF did not cause significant
changes in the physical or biological properties of the protein.
Aa anticipated,
the half-life of C3H]RAF-fetuin,
-24 h, was in
marked contrast to the 3- to 5-min half-life observed for the
asialo derivative
(9). Determination
of the acid precipitability
of ‘H radioactivity
recovered from plasma over a 72-h period
yielded 93 to 99% precipitability.
In experiments
with bovine serum albumin
(Fig. 3C), one
preparation
was labeled with lz51, while another was first
coupled with unlabeled
RAF, in a molar ratio of 51 (RAF:
albumin, determined
by anthrone),
and then iodinated by the
lactoperoxidase
technique
(20). The circulating
half-life
of
each preparation
was -24 h. In data not shown, the half-life
of a commercial
preparation
of L251-human serum albumin was
17 h. These data suggest that modification
of albumin with up
to 5 molecules of RAF did not cause either an increased or
decreased rate of uptake of albumin from the circulation.
Tissue Studies--In
order to verify the stability of r’H]RAF
in tissue following
protein
uptake, the hepatic recovery of
asialofetuin,
heat-denatured
albumin, and RNase B, labeled
with either “‘1 or [3H]RAF, was compared. Table II illustrates
that at early times postinjection
the extent of recovery of
radioactivity
from proteins
labeled by either method was
comparable.
However,
for iodinated
proteins, free iodide is
rapidly released from the liver upon degradation
of the protein (27). This loss is apparent even as early as 30 min, and by
24 h only traces of “‘1 were recovered in liver from either lz51labeled asialofetuin
or RNase B. In marked contrast, however,
at 24 to 96 h, significant
(90 to 60%)
amounts
of “H from
[“H]RAF/asiaIofetuin
were still present in liver. Over a 96-h
time period, “H radioactivity
declined from 90% of dose at
30 mm to 60% of dose at 96 h, giving an approximate
half-life
of 109 h. The recovery of radioactivity
from liver at 24 and 48

72

104

(HOURS)

cpm (0.4 mg) of [3H]RAF-asialofetuin;
0--O,
10 X 10” cpm (0.05
mg) of ‘*‘I-RNase
B; M,
5 x 10” cpm (0.3 mg) of [‘H]RAFRNase
B. Panel B, D----o,
7 X 10” (0.1 mg) of lp51-fetuin;
H,
5 x lo5 cpm (0.5 mg) of r’H]RAF-fetuin.
Panel C, W,
17 X 10”
cpm (0.3 mg) of ‘251-albumin;
W,
17 x 10” cpm (0.3 mg) of “‘1
(5 mol of raffinose/mol)-albumin.

Hepatic

recovery

Time postinjection
h
0.15
0.5
24.0
48.0
72.0
96.0

TABLE
II
of radioactivity
from “‘Zlabeled proteins
% injected dose”
Asialofetuinn

90
58
<I

-Cl

and

f3HJraffinoseHeat-denatured albumin

RN&se Bh

90
86
74
60
60

20
Cl

22.5
26.5
19.0

38
32
36

” Livers were removed
at indicated
times postinjection
and homogenized,
and radioactivity
was determined
in aliquots
of homogenate
as described
under
“Experimental
Procedures.”
Results
are the average value from at least two rats/time
point which typically
differed
by less than 5 percentage
points.
’ Animals
were injected
with 2 to 5 x lo6 cpm of ““I- or [“HIRAFlabeled proteins.

h postinjection,
90 and 74%, was matched by a concomitant
appearance
of 14 and 26% of dose, respectively,
in urine at
these two times. Radioactivity
in lung, kidneys, spleen, and
heart
at these same time points accounted in toto for less than
1% of dose. These data demonstrate
that the radioactivity
lost
from liver following
uptake of cH]RAF-asialofetuin
was not
reutilized
by other tissues but was excreted in the urine. In
contrast to the gradual decline of recovered
radioactivity
following

asialofetuin

injections,

radioactivity

from

[“HIRAF-

heat-denatured
albumin
or RNase B appeared to be more
stable over a 48- to 72-h period. RNase B experiments
were
limited to 48 h because the animals had been nephrectomized.
Since asialofetuin
is known to be cleared in hepatocytes
(9),
whereas RNase B and heat-denatured
albumin are cleared in
hepatic non-parenchymal
cells (2, 6), differences observed in
the stability
of the RAF
label
from
asialofetuin
or heat-denatured albumin and RNase B injections
may reflect differ-

Downloaded from http://www.jbc.org/ at USC SCHOOL OF MEDICINE on September 30, 2014

IO

I

Determination

of Sites of Catabolism
Hepatic

Time
postinjection

subcellular

TABLE IV
distribution
of radioactivity
recovered
[3HJraffinose
proteins
‘5 recovered radioactivity”
in subcellular fraction

[“H]RAF-asialofetuinh
Mitochondrial

Nuclear

13
17

]‘H]RAF-denatured
Supernatant

lylzloh
0.5
24.0
72.0
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Proteins

83
74

from

albumin”

Nuclear

Mitchondrial lysosomal

20

70

10

13

76

11

4
9

S”~~~~-

” Recoveries
of radioactivity
in fractions
were 85 to 100% of that
found in the whole homogenate.
h Animals
injected
with 2.5 x 10” cpm of [‘HIRAF-asialofetuin
and
4 x IO” [“HIRAF-heat-denatured
albumin;
livers
were removed
at
indicated
times and weighed
portions
homogenized
in 0.25 M sucrose
followed
by differential
centrifugation
to obtain subcellular
fractions
described
under “Experimental
Procedures.”

0.
30

40

U NKNOWN-+O
MWP 1100

50

I
70

60

\

\

Hepatic

cell type

Time postinjection

from

[“H]RAF-asialofetuin”

[‘HIRAF-heat-denatured albumin”

sp. act, pc”
sp. act. NPC

h
0.5
24.0
48.0
72.0

STACHYOSE

TABLE III
of recovery
of radioactivity
labeled proteins

Calculated
R cpm in
pc’

9.2

95

6.7
12.1

93
96

sp. act. NPC”
sp. act. PC

+‘O
\

[3H]raffinose-

RAFFINOSE

--,

MELIBIOSE

-

0
\
-+‘o

Calculated
% cpm in
NPC’

31
12.2

94
86

11

85

” Animals
were injected
with 2 x 10” cnm
of T”HlRAF-asialofetuin
_
_~
or 4 x Id cpm of [“Hlraffinose-heat-denatured
albumin.
* The ratio of specific activity (sp. act.) is based on the counts per
min/cell
of the purified
parenchymal
(PC) and nonparenchymal
(NPC)
cells obtained
from livers at indicated
times after collagenase
perfusion
and differential
centrifugation
as described
under “Experimental Procedures.”
Average
purities
of each cell type were 96 to 99%
and average
recoveries
of parenchymal
and non-parenchymal
cells
were 70 and 30% of cells in the initial
cell suspension
of liver,
respectively.
’ Calculated
per cent of radioactivity
in parenchymal
or non-parenchymal
cells in whole liver based on ratio of specific
activities
and
observed
average
ratio of parenchymal/nonparenchymal
cells of 2.

GALACTOSE

\
4

0

I,,&, , , , , , , ,
#30

I
vo

40

FRACTION

50

60

70

NUMBER

FIG. 4. Bio-Gel
P-2 chromatography
of soluble
radioactivity
recovered
after administration
of [3H]RAF-proteins.
Panel A, animals
were injected
with [:‘H]RAF-asialofetuin
([“HIRAF-ASF,
X-X)
or
[“HIRAF-heat-denatured
albumin
([“H]RAF-HDA,
M)
and
killed after 24 h, and soluble radioactivity
was recovered
after freezethaw of liver as described
under “Experimental
Procedures.”
Column
dimensions,
110 X 1.5 cm; fraction
size, 2.5 ml. Panel B, calibration
of
P-2 column
with carbohydrate
standards:
stachyose
(666), raffinose
(504), melibiose
(342), galactose
(180) detected
with anthrone.
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ences in the rate of turnover of cells or lysosomal contents in
one cell type from another. In these experiments
radioactivity
not recovered in liver could be accounted for in blood and
tissues of the reticuloendothelial
system (see “Discussion”).
The total body and hepatic distribution
of radioactivity
following inject,ion of [“H]RAF-RNase
B was essentially identical
to that previously reported for ““I-RNase
B (6).
Cell
Separations-As
a test of whether
the RAF label
would affect the known cellular sites of clearance of asialofetuin and heat-denatured
albumin by parenchymal
and nonparenchymal
cells, respectively,
the cell type in which radioactivity was localized after injection of each of these proteins
was determined.
Table III demonstrates
that, based on the
ratio of the specific activity (counts per min/cell)
of the final
purified parenchymal
and non-parenchymal
cell fractions, and
an average ratio of two parenchymal
cells/non-parenchymal
cell in the initial cell suspension of liver (2&S),greater than 90%
of the radioactivity
from [“HIRAF-asialofetuin
injections was
accounted for in hepatocytes.
By a similar calculation,
85 to
90% of the hepatic radioactivity
from heat-denatured
albumin
experiments was initially present in non-parenchymal
cells. In
experiments
to be reported
in detail elsewhere, [“HIRAFRNase B was also recovered primarily
(>85%) in non-parenchymal cells at 0.5 to 24 h postinjection.
There is some
variation
in relative specific activities of the two cell types
among experiments, but this probably results from day to day
variations
in the cell isolation technique.
The preferential
localization
of asialofetuin,
heat-denatured
albumin,
and
RNase B in the expected cell type supports the hypothesis
that the attachment
of RAF does not affect specific cellular
uptake of proteins by pinocytic
(asialofetuin,
RNase B) or
phagocytic (heat-denatured
albumin) processes.
Subcellular
Localization-The
expected lysosomal localization of recovered radioactivity
from [3H]RAF-labeled
proteins is illustrated
in Table IV. The data also indicated that in
addition to being stable in the liver for extended periods, the
radioactivity
from [“HIRAF
protein injections
remained
in
the lysosomally enriched subcellular fraction over a 48- to 72h period. The recovery of the lysosomal marker enzyme P-Nacetylhexosaminidase
exactly paralleled
that found for the
radioactivity.
Characterization
of Degradation
Products-Fig.
4 shows

of Circulating
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the gel chromatographic
profile of the soluble radioactivity
recovered after freeze-thaw
of livers obtained 24 h after administration
of either [3H]RAF-labeled
asialofetuin
or heatdenatured
albumin.
Essentially
identical
profiles were also
found for degradation
products obtained from livers at 72 and
96 h postinjection
of [“H]RAF-labeled
heat-denatured
albumin and asialofetuin,
respectively.
Based on the calibration
curve shown in Fig. 4B, the molecular weight of the unknown
peak was approximately
1100. Since essentially
100% of dose
from asialofetuin
injections was accounted for by the sum of
recovered radioactivity
in liver and urine, it seems likely that
the entire RAF molecule is recovered
attached to a small
peptide derived from the protein. Paper chromatography
of
hydrolysates
of the degradation
products recovered from the
P-2 column indicated that both radioactive
fructose and glucose are recovered in a ratio essentially identical to that found
for the starting protein.
A major gap in our knowledge of the metabolism
of plasma
proteins is the lack of essential information
on the regulation
of homeostatic
concentrations
of these proteins in plasma. To
understand
how plasma protein metabolism
is regulated, it is
at least necessary to identify the sites of catabolism
of these
proteins. The experiments
described in this report represent
an effort to overcome a major obstacle in the accurate determination of these sites of catabolism,
namely that, although
these proteins are delivered to tissues at a relatively slow rate
(e.g. tlrz r 24 h), rates of degradation
in tissues (e.g. tlr2 5 15
min) are relatively
rapid. Thus, any radioactive
tracer attached to protein is lost from the site of uptake at a rate too
great to allow quantitation.
We sought to develop an inert, indigestible
radioactive
tag
which would accumulate
at the tissue site of a protein’s
degradation
and, thus, measure the cumulative
degradation
of the protein in that tissue. Sucrose seemed especially attractive as a radioactive
ligand for this purpose because of its
demonstrated
stability
in lysosomes. Recently,
based on a
similar rationale,
Pittman
and Steinberg
(29) reported
the
attachment
of [14C]sucrose to low density lipoprotein
and
albumin, via a succinate spacer arm. Their in vitro studies of
the uptake of the labeled proteins by cells in culture demonstrated both accumulation
and stability
of the radioactive
label in cells over a 6-h period. While these initial observations
are promising,
there are limitations
inherent in this method
for attaching sucrose to protein. The attachment
through the
succinate spacer alters the charge of protein both by conversion of an amine to an amide function
and by addition
of
negative charge from uncoupled
succinate groups on the sucrose moiety. In addition,
the ester linkage between sucrose
and the linking
succinate arm may well be susceptible
to
plasma esterases in viva In contrast, use of reductive amination to couple RAF, and thus sucrose, to protein results in
minimal
alterations
in charge and isoelectric
point of the
modified protein. Further, we have observed that the label is
completely
stable under in viuo conditions.
As noted above,
the coupling procedure
can be performed
under mild, physiological conditions
and does not result in any modification
of
gel chromatographic
behavior
of the proteins studied or the
enzymatic activity of RNase B. The studies presented
also
document
that the kinetics and sites of clearance of RAFlabeled proteins are essentially
identical
to those found for
‘?-labeled
proteins, suggesting that, in fact, there is no major
alteration
in the physical and biological
properties
of the
modified proteins.
A basic assumption in the choice of sucrose as in indigestible
tracer is the absence of sucrase or ,&fructofuranosidase
activ-
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ities in mammalian
lysosomes. There has been, however, a
report of a low but detectable
level of sucrase in rat liver
lysosomes (30). As shown above, while the RAF label is
particularly
stable in non-parenchymal
cells, there was a
measurable
loss of the RAF radioactivity
with time from
hepatocytes.
This could result from normal hepatocyte
turnover but is unlikely to result from enzymatic degradation
of
the RAF-amino
acid conjugate.
As noted above, 100% of
injected dose of [“H]RAF-asialofetuin
could be accounted for
in liver and urine at all times. In addition,
only a single low
molecular
weight species was detected on Bio-Gel P-2 from
either of these sources, for as long as 96 h postinjection,
and
contained both glucose and fructose in the expected ratios.
These data suggest that either RAF attached to protein is not
a suitable substrate for the sucrase described by Horvat (30)
or that the sucrase activity is too low to be detectable during
the course of our experiments.
It should also be noted that,
since the loss of radioactivity
from hepatocytes
is not detectable for at least 24 h postinjection
and has an approximate
half-life of 100 h, experiments
to study the sites of uptake of
proteins with long circulating
half-lives
can be carried out
over at least a 48-h period, with little loss of accumulating
radioactivity
in parenchymal
cells, should this prove to be a
site of uptake.
The emphasis of the experiments
reported here has been to
study the stability of the [3H]RAF label in liver, as a model
for its stability in other tissues. The data obtained
to date
verify this stability in liver and in the lysosomal subcellular
fraction of both hepatic cell types. In preliminary
studies,
radioactivity
not found in liver from [3H]RAF-heat-denatured
albumin injections could be accounted for primarily
in kidney,
spleen, and lung, other organs of the reticuloendothelial
system expected to participate
in the clearance of aggregated
protein
(2). The recovery
of radioactivity
in these organs
appears to have a stability comparable
to that found for liver,
and only 6.5% of dose was found in urine over a 72-h period.
The uptake of RNase B also occurs in organs of the reticuloendothelial
system, but a large proportion
is found in muscle
and hide (6). Thus, this protein
should also be useful for
evaluating
the stability of RAF in nonhepatic
tissue.
Since the ultimate
goal of our research is to investigate
regulation
of plasma protein catabolism,
it was essential to
document
that the RAF label did not interfere
with normal
mechanisms of clearance or elicit clearance by different pathways. The recovery of asialofetuin
in hepatocytes
and RNase
B and heat-denatured
albumin
in non-parenchymal
cells of
liver suggests that the normal mechanisms
of clearance were
operating
on RAF-labeled
proteins. The fact that ?- and
RAF-labeled
fetuin and albumin were cleared from the circulation with similar kinetics also suggests that attachment
of
RAF did not interfere with the normal uptake mechanisms
for these proteins.
One other important
aspect of the use of RAF as a label is
that it should accumulate
with time in the tissues active in
catabolism of long lived proteins, as protein is slowly delivered
to those tissues. In one set of preliminary
experiments
studying the hepatic recovery of [3H]RAF-fetuin
(circulating
halflife, -24 h), the recovery of radioactivity
at 12, 24, and 48 h
postinjection
was 21, 29, and 36% of dose, respectively.
At
these same times there was a concomitant
decrease in radioactivity in plasma from 41 to 23 to 12% of dose (Fig. 3). These
encouraging
initial findings with [3H]RAF-fetuin
are entirely
consistent with the hypothesis that the recovery of the RAF
label from a protein with a long plasma half-life would show
a progressive increase in a tissue involved in the catabolism of
that protein, as it is slowly removed from the circulation.
An
additional
7 and 14% of dose from C3H]RAF-fetuin
was re-
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covered in urine at 24 and 48 h postinjection.
Thus, blood,
liver, and urine accounted for about 60% of dose at the three
times studied. The remainder
of radioactivity
could be accounted for in other visceral organs and extravascular
compartments.
Details of these experiments
will be presented
elsewhere.
In summary,
from the experiments
presented
above, we
conclude that [3H]RAF functions as a biologically
inert, indigestible tracer which accumulates
in tissues following protein
removal from the circulation
and intracellular
degradation
in
lysosomes. We believe that the technology
which we have
developed here provides an exciting new tool for investigating
the sites, and eventually,
the regulation
of plasma protein
catabolism
in uiuo.
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